StonvexLoading…
StonvexStonvexStonvexCore line items from MASI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 2026-04-04 | Annual 2026 2026-01-03 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $403.60M | $1.53B | $1.11B | $742.90M |
Operating Income | $77.40M | $310.00M | $226.10M | $142.50M |
Net Income | $57.10M | $-151.50M | $-219.80M | $51.30M |
EPS (Diluted) | $1.09 | $-2.80 | $-4.01 | $-2.17 |
Total Assets | $1.64B | $1.70B | $1.82B | $2.40B |
Total Liabilities | $853.80M | $977.70M | $1.01B | $1.36B |
Cash & Equivalents | $124.60M | $152.30M | $312.30M | $149.60M |
Free Cash Flow OCF − CapEx | $41.00M | $198.40M | $145.00M | $94.10M |
Shares Outstanding | 52.40M | 52.10M | 53.10M | 54.30M |